Search
Matt Callahan said the product received an excellent safety profile.

Botanix up on study results

Shares in medical dermatology company Botanix Pharmaceuticals, led by Perth-based chairman Graham Griffiths and executive director Matt Callahan, have jumped more than 20 per cent today after the company announced successful results from an acne patient study.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/03/19

1 year TSR5 year TSR
86thCFOAM48%
192ndQuestus13%-8%
203rdBabylon Pump & Power11%82%
215thBotanix Pharmaceuticals8%11%
807thQuantify Technology Holdings-80%-74%
729 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

27/04/18
$19k Bought
27/04/18
$94k Sold
27/04/18
$25k Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

121st↑Botanix Pharmaceuticals$1.8m
124th↑Babylon Pump & Power$1.6m
125th↓Questus$1.6m
127th↑Quantify Technology Holdings$1.4m
128th↑CFOAM$1.4m
201 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer